NCT01344655
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Airway Disease Section, NHLI, Imperial College London London, United Kingdom
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
787 public trials
11 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT00139932
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
Not specified
Completed
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.
NCT00519376
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Wiesbaden, Hesse, Germany
- GSK Investigational Site Mainz, Rhineland-Palatinate, Germany
- GSK Investigational Site Berlin, State of Berlin, Germany
- GSK Investigational Site Berlin, State of Berlin, Germany
NCT00292552
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Rancho Mirage, California, United States
- GSK Investigational Site Torrance, California, United States
- GSK Investigational Site Denver, Colorado, United States
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site DeLand, Florida, United States
NCT01772147
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site DeLand, Florida, United States
NCT01751113
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Ibaraki, Japan
- GSK Investigational Site Osaka, Japan
NCT02096731
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada
Completed
A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients
NCT00478738
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Mainz, Rhineland-Palatinate, Germany
- GSK Investigational Site Berlin, State of Berlin, Germany
- GSK Investigational Site Bloemfontein, South Africa
- GSK Investigational Site George, South Africa
NCT02512549
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +6 more
- Locations
-
- All India Institute of Science and Technology Delhi, National Capital Territory of Delhi, India